1. Home
  2. HYPR vs ATRA Comparison

HYPR vs ATRA Comparison

Compare HYPR & ATRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Hyperfine Inc.

HYPR

Hyperfine Inc.

HOLD

Current Price

$0.79

Market Cap

101.3M

Sector

Health Care

ML Signal

HOLD

Logo Atara Biotherapeutics Inc.

ATRA

Atara Biotherapeutics Inc.

HOLD

Current Price

$9.57

Market Cap

81.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HYPR
ATRA
Founded
2014
2012
Country
United States
United States
Employees
N/A
N/A
Industry
Medical Specialities
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
101.3M
81.2M
IPO Year
2021
2014

Fundamental Metrics

Financial Performance
Metric
HYPR
ATRA
Price
$0.79
$9.57
Analyst Decision
Strong Buy
Sell
Analyst Count
4
2
Target Price
$1.59
$5.00
AVG Volume (30 Days)
489.6K
50.8K
Earning Date
05-12-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
23.21
122.52
EPS
N/A
N/A
Revenue
$13,563,000.00
$120,772,000.00
Revenue This Year
$50.75
N/A
Revenue Next Year
$29.71
N/A
P/E Ratio
N/A
N/A
Revenue Growth
5.22
N/A
52 Week Low
$0.79
$3.92
52 Week High
$2.22
$19.15

Technical Indicators

Market Signals
Indicator
HYPR
ATRA
Relative Strength Index (RSI) 29.06 54.82
Support Level N/A $8.98
Resistance Level $1.39 $10.02
Average True Range (ATR) 0.04 0.53
MACD 0.00 0.06
Stochastic Oscillator 5.22 34.39

Price Performance

Historical Comparison
HYPR
ATRA

About HYPR Hyperfine Inc.

Hyperfine Inc is a medical device company that created Swoop. The Swoop Portable MR Imaging System produces high-quality images at a lower magnetic field strength than conventional MRI scanners. The company derives its revenue from sale of sales of MRI devices and service sales, which consist of sales from subscriptions of bundled devices, maintenance, and software. The company is in the health technology business with a mission to revolutionize patient care globally through accessible, affordable, clinically relevant artificial intelligence (AI)-powered portable ultra-low-field (ULF) magnetic resonance (MR) brain imaging. The Company operates in one business segment, which includes all activities related to production, supply, service, and commercialization of the Swoop system.

About ATRA Atara Biotherapeutics Inc.

Atara Biotherapeutics Inc operates in the United States healthcare sector. It focuses on developing transformative therapies for patients with serious diseases, including solid tumors, hematologic cancers, and autoimmune diseases. It operates and manages business as one operating and reportable segment which is the business of developing therapeutics. The company's product candidates comprise Tab-cel, ATA3431, and ATA3219.

Share on Social Networks: